APAH PoPH
Showing 1 - 4 of 4
Systemic Sclerosis, Pulmonary Hypertension Trial in Heidelberg (Ambrisentan, Placebo)
Completed
- Systemic Sclerosis
- Pulmonary Hypertension
- Ambrisentan
- Placebo
-
Heidelberg, GermanyThoraxclinic at the University of Heidelberg
Apr 17, 2020
Portopulmonary Hypertension, Pulmonary Hypertension, Cirrhosis, Liver Trial in New Orleans (Ambrisentan Pill, Tadalafil Pill)
Withdrawn
- Portopulmonary Hypertension
- +2 more
- Ambrisentan Pill
- Tadalafil Pill
-
New Orleans, LouisianaOchsner Clinic Foundation
Dec 5, 2018
Treprostinil to Facilitate Liver Transplantation in
Completed
- Portopulmonary Hypertension
- +2 more
-
Los Angeles, California
- +3 more
Jan 5, 2017
Pulmonary Arterial Hypertension Trial in Canada, United States (Ventripoint Medical System)
Completed
- Pulmonary Arterial Hypertension
- Ventripoint Medical System
-
Chicago, Illinois
- +6 more
Mar 25, 2015